Literature DB >> 15266616

The 11q terminal deletion disorder: a prospective study of 110 cases.

Paul D Grossfeld1, Teresa Mattina, Zona Lai, Remi Favier, Ken Lyons Jones, Finbarr Cotter, Christopher Jones.   

Abstract

We performed a prospective study of 110 patients (75 not previously published) with the 11q terminal deletion disorder (previously called Jacobsen syndrome), diagnosed by karyotype. All the patients have multiple dysmorphic features. Nearly all the patients (94%) have Paris-Trousseau syndrome characterized by thrombocytopenia and platelet dysfunction. In total, 56% of the patients have serious congenital heart defects. Cognitive function ranged from normal intelligence to moderate mental retardation. Nearly half of the patients have mild mental retardation with a characteristic neuropsychiatric profile demonstrating near normal receptive language ability, but mild to moderate impairment in expressive language. Ophthalmologic, gastrointestinal, and genitourinary problems were common, as were gross and fine motor delays. Infections of the upper respiratory system were common, but no life-threatening infections were reported. We include a molecular analysis of the deletion breakpoints in 65 patients, from which genetic "critical regions" for 14 clinical phenotypes are defined, as well as for the neuropsychiatric profiles. Based on these findings, we provide a comprehensive set of recommendations for the clinical management of patients with the 11q terminal deletion disorder.

Entities:  

Mesh:

Year:  2004        PMID: 15266616     DOI: 10.1002/ajmg.a.30090

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  80 in total

1.  Hypoplastic left heart syndrome in patients with Kabuki syndrome.

Authors:  M Cristina Digilio; Anwar Baban; Bruno Marino; Bruno Dallapiccola
Journal:  Pediatr Cardiol       Date:  2010-10       Impact factor: 1.655

2.  Recurrent 70.8 Mb 4q22.2q32.3 duplication due to ovarian germinal mosaicism.

Authors:  Lucie Tosca; Sophie Brisset; François M Petit; Laure Lecerf; Ghislaine Rousseau; Cécile Bas; Mireille Laroudie; Marie-Laure Maurin; Sylvie Tapia; Olivier Picone; Sophie Prevot; Michel Goossens; Philippe Labrune; Gérard Tachdjian
Journal:  Eur J Hum Genet       Date:  2010-04-28       Impact factor: 4.246

Review 3.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

4.  An interspecies heart-to-heart: Using Xenopus to uncover the genetic basis of congenital heart disease.

Authors:  Alexandra MacColl Garfinkel; Mustafa K Khokha
Journal:  Curr Pathobiol Rep       Date:  2017-05-06

Review 5.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

6.  FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.

Authors:  Karen K Vo; Danuta J Jarocha; Randolph B Lyde; Vincent Hayes; Christopher S Thom; Spencer K Sullivan; Deborah L French; Mortimer Poncz
Journal:  Blood       Date:  2017-04-21       Impact factor: 22.113

Review 7.  Inherited platelet disorders: thrombocytopenias and thrombocytopathies.

Authors:  Giovanna D'Andrea; Massimiliano Chetta; Maurizio Margaglione
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

8.  Linkage analysis of left ventricular outflow tract malformations (aortic valve stenosis, coarctation of the aorta, and hypoplastic left heart syndrome).

Authors:  Kim L McBride; Gloria A Zender; Sara M Fitzgerald-Butt; Daniel Koehler; Andres Menesses-Diaz; Susan Fernbach; Kwanghyuk Lee; Jeffrey A Towbin; Suzanne Leal; John W Belmont
Journal:  Eur J Hum Genet       Date:  2009-01-14       Impact factor: 4.246

9.  Chromosomal microarray mapping suggests a role for BSX and Neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome).

Authors:  C D Coldren; Z Lai; P Shragg; E Rossi; S C Glidewell; O Zuffardi; T Mattina; D D Ivy; L M Curfs; S N Mattson; E P Riley; M Treier; P D Grossfeld
Journal:  Neurogenetics       Date:  2008-10-15       Impact factor: 2.660

10.  Identification of subtelomeric genomic imbalances and breakpoint mapping with quantitative PCR in 296 individuals with congenital defects and/or mental retardation.

Authors:  Bernd Auber; Verena Bruemmer; Barbara Zoll; Peter Burfeind; Detlef Boehm; Thomas Liehr; Knut Brockmann; Ekkehard Wilichowski; Loukas Argyriou; Iris Bartels
Journal:  Mol Cytogenet       Date:  2009-03-12       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.